What is King Pharmaceuticals's market capitalization?

King Pharmaceuticals (KG) reported market capitalization of $83.61M in Q1 2026.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.

King Pharmaceuticals KG Market capitalization

Market capitalization at other companies

Arch Capital GroupACGL

$34.2B-5.4%

Everest GroupEG

$13.2B-15.4%

SiriusPointSPNT

$2.52B+25.6%

KKR & Co.KKR

$82.47B-19.7%

Skyward Specialty Insurance Group, Inc.SKWD

$1.95B-8.8%

Tiptree Inc.TIPT

——

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Computed from the period-end share price: $83.61M.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's market capitalization?: King Pharmaceuticals (KG) reported market capitalization of $83.61M in Q1 2026.
What does market capitalization mean?: The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.